AQR Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
AQR Capital Management's IMVT Position: Q3 2026 in Review
AQR Capital Management increased its Immunovant (IMVT) stake by 136% in Q3 2026, buying an estimated $595K and bringing the position to 26,180 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #3131.
AQR Capital Management first reported a position in IMVT in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.91M in Q4 2023. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- AQR Capital Management held 26,180 shares of Immunovant worth $884K as of Q3 2026.
- AQR Capital Management bought 15,098 Immunovant shares in Q3 2026, an estimated $595K.
- Immunovant made up ﹤0.01% of AQR Capital Management's portfolio in Q3 2026, its #3131 holding.
- AQR Capital Management first reported a position in Immunovant in Q1 2023 and has held it in 9 quarters since.
- AQR Capital Management's Immunovant position peaked at $2.91M in Q4 2023.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.